The National Institute of High Security Animal Diseases (NIHSAD) in Bhopal has achieved success in developing a vaccine to safeguard birds against the bird flu virus. It is the first locally produced bird flu vaccine in the nation.
As of today, the vaccination has been imported to prevent the spread of this virus. On the ninth anniversary of NIHSAD in Bhopal’s foundation, Dr. Bhupendra Nath Tripathi, deputy director general of the Indian Council of Agricultural Research, travelled from Delhi on Monday to launch the vaccine. Along with other experts, Dr. VP Singh, director of NIHSAD Bhopal, attended this event.
The NIHSAD is one of India’s premier institutes for researching new and exotic animal pathogens.
Dr. Tripathi said that the bird flu subtype H9N2 kills millions of chickens and other birds each year, preventing them from being able to lay eggs. The H9N2 virus comes in two types. The first virus is low pathogenic, and the second is high pathogenic. The chickens will be protected from low pathogenic viruses by the vaccine.
A high pathogenic avian influenza mortality rate can reach approximately 100% in chickens. He said that the institute would shortly distribute the vaccination formula to private entities.
Animal scientists estimate that a chicken raised in a poultry farm has a six-month lifespan. The vaccination will be given within this six-month period.